HepG2, THP-1, and RAW 264.7 cells were obtained from the ATCC (Manassas, VA). Anacetrapib was obtained from Acorn Pharmatech (Redwood City, CA) and dalcetrapib was produced and provided by Hoffmann-La Roche Ltd. (Basel, Switzerland).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.